Post-approval studies (Phase 4)Study completedNCT02941367
What this trial is testing
Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan
Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 184